tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

RPRX Stock Latest News

Royalty Pharma price target raised to $39 from $38 at BofA
The FlyRoyalty Pharma price target raised to $39 from $38 at BofA
1M ago
RPRX
Ex-Dividend Date Nearing for These 10 Stocks – Week of November 11, 2024
PremiumMarket News
Ex-Dividend Date Nearing for These 10 Stocks – Week of November 11, 2024
1M ago
AJX
BRY
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
RDY
TAK
Geron announces $375M in synthetic royalty, debt financings with Royalty Pharma
PremiumThe Fly
Geron announces $375M in synthetic royalty, debt financings with Royalty Pharma
1M ago
GERN
RPRX
Royalty Pharma to acquire royalty interest in Geron’s RYTELO for $125M
PremiumThe Fly
Royalty Pharma to acquire royalty interest in Geron’s RYTELO for $125M
1M ago
GERN
RPRX
Royalty Pharma Reports Strong Q3 2024 Results
PremiumCompany AnnouncementsRoyalty Pharma Reports Strong Q3 2024 Results
2M ago
RPRX
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
2M ago
BCRX
NKTR
Royalty Pharma reports Q3 revenue $565M, consensus $696.1M
Premium
The Fly
Royalty Pharma reports Q3 revenue $565M, consensus $696.1M
2M ago
RPRX
Royalty Pharma enters $350M synthetic royalty funding agreement with Syndax
PremiumThe Fly
Royalty Pharma enters $350M synthetic royalty funding agreement with Syndax
2M ago
RPRX
SNDX
Syndax, Royalty Pharma enter $350M royalty funding agreement for Niktimvo
PremiumThe Fly
Syndax, Royalty Pharma enter $350M royalty funding agreement for Niktimvo
2M ago
RPRX
SNDX
Morgan Stanley Predicts Up to 670% Jump for These 2 ‘Strong Buy’ Stocks
PremiumStock Analysis & Ideas
Morgan Stanley Predicts Up to 670% Jump for These 2 ‘Strong Buy’ Stocks
2M ago
RPRX
TNYA
Royalty Pharma price target lowered to $40 from $60 at Citi
PremiumThe Fly
Royalty Pharma price target lowered to $40 from $60 at Citi
2M ago
RPRX
Royalty Pharma Strikes Deal on FDA-Approved Schizophrenia Drug
PremiumCompany AnnouncementsRoyalty Pharma Strikes Deal on FDA-Approved Schizophrenia Drug
3M ago
8K
RPRX
PureTech Health announces FDA approval of KarXT
Premium
The Fly
PureTech Health announces FDA approval of KarXT
3M ago
BMY
PRTC
Royalty Pharma price target raised to $51 from $50 at Goldman Sachs
Premium
The Fly
Royalty Pharma price target raised to $51 from $50 at Goldman Sachs
4M ago
RPRX
DRI Healthcare Trust upgraded to Buy from Hold at Stifel
PremiumThe Fly
DRI Healthcare Trust upgraded to Buy from Hold at Stifel
4M ago
RPRX
Royalty Pharma reports Q2 revenue $537M, consensus $628.52M
PremiumThe Fly
Royalty Pharma reports Q2 revenue $537M, consensus $628.52M
5M ago
RPRX
Royalty Pharma Bets Big on Voranigo’s Market Success
PremiumCompany Announcements
Royalty Pharma Bets Big on Voranigo’s Market Success
5M ago
8K
RPRX
Royalty Pharma appoints Sawaya as EVP, Head of Human Capital
PremiumThe Fly
Royalty Pharma appoints Sawaya as EVP, Head of Human Capital
5M ago
RPRX
Royalty Pharma price target raised to $51 from $48 at Morgan Stanley
PremiumThe FlyRoyalty Pharma price target raised to $51 from $48 at Morgan Stanley
5M ago
AGIO
PTCT
Agios Pharmaceuticals price target raised to $53 from $44 at RBC Capital
Premium
The Fly
Agios Pharmaceuticals price target raised to $53 from $44 at RBC Capital
7M ago
AGIO
RPRX
Royalty Pharma downgraded to Neutral from Buy at UBS
Premium
The Fly
Royalty Pharma downgraded to Neutral from Buy at UBS
7M ago
RPRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >